| The MYC enhancer-ome: long-range transcriptional regulation of MYC in cancer O Lancho, D Herranz Trends in cancer 4 (12), 810-822, 2018 | 105 | 2018 |
| SHMT inhibition is effective and synergizes with methotrexate in T-cell acute lymphoblastic leukemia JC García-Cañaveras, O Lancho, GS Ducker, JM Ghergurovich, X Xu, ... Leukemia 35 (2), 377-388, 2021 | 84 | 2021 |
| A Tumor Suppressor Enhancer of PTEN in T-cell Development and Leukemia L Tottone, O Lancho, JW Loh, A Singh, S Kimura, J Roels, A Kuchmiy, ... Blood cancer discovery 2 (1), 92-109, 2021 | 16 | 2021 |
| A novel and highly effective mitochondrial uncoupling drug in T-cell leukemia V da Silva-Diz, B Cao, O Lancho, E Chiles, A Alasadi, M Aleksandrova, ... Blood, The Journal of the American Society of Hematology 138 (15), 1317-1330, 2021 | 11 | 2021 |
| A Therapeutically Targetable NOTCH1–SIRT1–KAT7 Axis in T-cell Leukemia O Lancho, A Singh, V da Silva-Diz, M Aleksandrova, J Khatun, L Tottone, ... Blood cancer discovery 4 (1), 12-33, 2023 | 6 | 2023 |
| Therapeutic targeting of ACLY in T-ALL in vivo V Silva-Diz, A Singh, O Lancho, M Aleksandrova, K Mandleywala, ... bioRxiv, 2023.03. 27.534395, 2023 | | 2023 |
| Sirt1 Is a Novel Therapeutic Target in T-ALL O Lancho, A Singh, V da Silva-Diz, PR Nunes, L Tottone, S Luo, ... Blood 138, 2221, 2021 | | 2021 |
| SIRT1 is a novel therapeutic target in T-ALL O Lancho, V da Silva-Diz, S Luo, A Singh, H Khiabanian, D Herranz Cancer Research 80 (16_Supplement), 3723-3723, 2020 | | 2020 |
| A tumor suppressor enhancer of PTEN in T-cell development and transformation L Tottone, O Lancho, MV da Silva-Diz, S Luo, S Chakraborty, PP Rocha, ... Cancer Research 80 (16_Supplement), 3434-3434, 2020 | | 2020 |
